Ibrutinib
Drug timelines are a Plus or Pro feature.
173 regulatory and trial events tracked for Ibrutinib, covering 2014-02-13 to 2026-06-09. Get the full timeline:
Most recent: Clinical Trial Results: Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia [Phase 2]